Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5176)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gordon M. 5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence. World J Gastrointest Pharmacol Ther 2017; 8(2): 99-102 [PMID: 28533918 DOI: 10.4292/wjgpt.v8.i2.99] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i2/99.htm |
| Number | Citing Articles |
| 1 |
Zipporah Iheozor-Ejiofor, Morris Gordon, Andrew Clegg, Suzanne C Freeman, Teuta Gjuladin-Hellon, John K MacDonald, Anthony K Akobeng. Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2019; 2019(9) doi: 10.1002/14651858.CD013210.pub2
|
| 2 |
Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kirandeep Kaur, Rajeev Khosla, Ajay Kumar, Ramit Mahajan, S. P. Misra, Kiran Peddi, Shivaram Prasad Singh, Arshdeep Singh. Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease. Intestinal Research 2020; 18(4): 355 doi: 10.5217/ir.2019.09176
|
| 3 |
Morris Gordon. Maintaining remission in Crohn’s disease post surgery: what can we learn from Cochrane?. Frontline Gastroenterology 2024; : flgastro-2023-102559 doi: 10.1136/flgastro-2023-102559
|
| 4 |
Jun Hwan Yoo, Stefan Holubar, Florian Rieder. Fibrostenotic strictures in Crohn’s disease. Intestinal Research 2020; 18(4): 379 doi: 10.5217/ir.2019.09148
|
| 5 |
Giovanni Santacroce, Marco Vincenzo Lenti, Antonio Di Sabatino. Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease. Cells 2022; 11(3): 429 doi: 10.3390/cells11030429
|
| 6 |
Andrew Clegg, Zipporah Iheozor-Ejiofor, Morris Gordon, John K MacDonald, Anthony K Akobeng. Interventions for maintenance of surgically-induced remission in Crohn’s disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013210
|
| 7 |
Bernd Bokemeyer, Sandra Plachta‐Danielzik, Romina di Giuseppe, Ulf Helwig, Niels Teich, Carsten Schmidt, Petra Hartmann, Christina Sobotzki, Stefan Schreiber. Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5‐year follow‐up data from the prospective BioCrohn study. Alimentary Pharmacology & Therapeutics 2023; 58(1): 35 doi: 10.1111/apt.17512
|
| 8 |
Ana Losa, Rita Gomes, Francisco Ribeiro Mourão, Sandra Soares Cardoso, Paula Manuel Vieira, Mário Rui Correia, Helena Moreira Silva, Gisela Silva, Marta Tavares, Ermelinda Santos Silva, Rosa Lima. Drug‐Related Adverse Reactions in Pediatric Inflammatory Bowel Disease. The Journal of Clinical Pharmacology 2024; 64(1): 103 doi: 10.1002/jcph.2339
|